Penthrox is launched in Italy
23 October 2019
ASX Announcement
Penthrox® is launched in Italy
Medical Developments International Ltd (ASX: MVP) is delighted to announce that Penthrox has been launched in Italy.
MVP CEO Mr. John Sharman said, “We are delighted to finally launch Penthrox in the important European market of Italy. There has been a number of clinical studies completed in preparation for the launch of Penthrox in Italy. In particular, a study of 272 trauma patients in 15 Italian emergency units (“MEDITA”), showed that Penthrox was SUPERIOR to Standard of Care, including Opioids, for adult trauma pain patients in Italy.”
For further details, please click on the following link – Penthrox is launched in Italy